The molecular basis of interstitial pulmonary fibrosis caused by antineoplastic agents.
Lazo
J S
JS
Department of Pharmacology, University of Pittsburgh, PA 15261.
Hoyt
D G
DG
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001761:Bleomycin / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D004249:DNA Damage; D005353:Fibronectins / Q000235:genetics / Q000378:metabolism; D008168:Lung / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D011347:Procollagen / Q000235:genetics / Q000378:metabolism; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000235:genetics / Q000378:metabolism
D000970:Antineoplastic Agents; D005353:Fibronectins; D011347:Procollagen; D012333:RNA, Messenger; D016212:Transforming Growth Factor beta; D001761:Bleomycin; D003520:Cyclophosphamide